118th Congress · HOUSE BILLBILL

H.R. 2297 — To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

“To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.”

Health

Introduced Mar 29, 2023

Last action Apr 7, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 29, 2023

Step 2

Referred

Apr 7, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill limits FY2024 funding for the Food and Drug Administration (FDA) Innovation Account, which the FDA uses to implement provisions of the 21st Century Cures Act relating to the development of medical products.

Provisions · 1 sectionsIntroduced in House

Timeline · 3 actions

Apr 7, 2023

Referred to the Subcommittee on Health.

Mar 29, 2023

Introduced in House

Mar 29, 2023

Referred to the House Committee on Energy and Commerce.